# The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine

> **NCT02558023** · PHASE3 · TERMINATED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 14 (actual)

## Conditions studied

- Hypertension
- Preeclampsia

## Interventions

- **DRUG:** Urapidil
- **DRUG:** Nicardipine

## Key facts

- **NCT ID:** NCT02558023
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** no candidats
- **Last updated:** 2020-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02558023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02558023, "The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02558023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*